Therapeutic Effects of HIF-1α on Bone Formation around Implants in Diabetic Mice Using Cell-Penetrating DNA-Binding Protein

Patients with uncontrolled diabetes are susceptible to implant failure due to impaired bone metabolism. Hypoxia-inducible factor 1α (HIF-1α), a transcription factor that is up-regulated in response to reduced oxygen during bone repair, is known to mediate angiogenesis and osteogenesis. However, its function is inhibited under hyperglycemic conditions in diabetic patients. This study thus evaluates the effects of exogenous HIF-1α on bone formation around implants by applying HIF-1α to diabetic mice and normal mice via a protein transduction domain (PTD)-mediated DNA delivery system. Implants were placed in the both femurs of diabetic and normal mice. HIF-1α and placebo gels were injected to implant sites of the right and left femurs, respectively. We found that bone-to-implant contact (BIC) and bone volume (BV) were significantly greater in the HIF-1α treated group than placebo in diabetic mice (p < 0.05). Bioinformatic analysis showed that diabetic mice had 216 differentially expressed genes (DEGs) and 21 target genes. Among the target genes, NOS2, GPNMB, CCL2, CCL5, CXCL16, and TRIM63 were found to be associated with bone formation. Based on these results, we conclude that local administration of HIF-1α via PTD may boost bone formation around the implant and induce gene expression more favorable to bone formation in diabetic mice.

[1]  D. Graves,et al.  Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation. , 2003, Endocrinology.

[2]  S. Khosla,et al.  Transforming growth factor beta 1 induces CXCL16 and leukemia inhibitory factor expression in osteoclasts to modulate migration of osteoblast progenitors. , 2013, Bone.

[3]  Y. Shin,et al.  HIF1A overexpression using cell-penetrating DNA-binding protein induces angiogenesis in vitro and in vivo , 2017, Molecular and Cellular Biochemistry.

[4]  P. Krebsbach,et al.  Osterix Enhances BMSC-associated Osseointegration of Implants , 2009, Journal of dental research.

[5]  Teresa Pereira,et al.  Stabilization of HIF-1α is critical to improve wound healing in diabetic mice , 2008, Proceedings of the National Academy of Sciences.

[6]  S. Glassman,et al.  Adverse Effects Associated With High-Dose Recombinant Human Bone Morphogenetic Protein-2 Use in Anterior Cervical Spine Fusion , 2006, Spine.

[7]  Cell-penetrating DNA-binding protein as a safe and efficient naked DNA delivery carrier in vitro and in vivo. , 2010, Biochemical and biophysical research communications.

[8]  P. Connell,et al.  High glucose concentrations alter hypoxia-induced control of vascular smooth muscle cell growth via a HIF-1alpha-dependent pathway. , 2007, Journal of molecular and cellular cardiology.

[9]  S. Bhang,et al.  Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery. , 2008, Biochemical and biophysical research communications.

[10]  C. Wilmowsky,et al.  Osseointegration of SLActive implants in diabetic pigs. , 2013, Clinical oral implants research.

[11]  Biomechanical evaluation of early fracture healing in normal and diabetic rats , 2000, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[12]  I. Cuthill,et al.  Reporting : The ARRIVE Guidelines for Reporting Animal Research , 2010 .

[13]  E. Hod,et al.  Efficacy of enrofloxacin in a mouse model of sepsis. , 2014, Journal of the American Association for Laboratory Animal Science : JAALAS.

[14]  P. Moy,et al.  Dental implant failure rates and associated risk factors. , 2005, The International journal of oral & maxillofacial implants.

[15]  J. Polak,et al.  Nitric oxide in fracture repair. Differential localisation, expression and activity of nitric oxide synthases. , 1999, The Journal of bone and joint surgery. British volume.

[16]  M. Quirynen,et al.  Impact of local and systemic factors on the incidence of oral implant failures, up to abutment connection. , 2007, Journal of clinical periodontology.

[17]  P. Branemark,et al.  Osseointegrated implants in the treatment of the edentulous jaw. Experience from a 10-year period. , 1977, Scandinavian journal of plastic and reconstructive surgery. Supplementum.

[18]  James A. Clark,et al.  Effects of buprenorphine, meloxicam, and flunixin meglumine as postoperative analgesia in mice. , 2011, Journal of the American Association for Laboratory Animal Science : JAALAS.

[19]  Yuanliang Huang,et al.  Repairing critical-sized calvarial defects with BMSCs modified by a constitutively active form of hypoxia-inducible factor-1α and a phosphate cement scaffold. , 2011, Biomaterials.

[20]  J. Dai,et al.  The Bone-Forming Effects of HIF-1α-Transduced BMSCs Promote Osseointegration with Dental Implant in Canine Mandible , 2012, PloS one.

[21]  G O Gallucci,et al.  Success Criteria in Implant Dentistry , 2012, Journal of dental research.

[22]  M. Bolander,et al.  Defects of early fracture-healing in experimental diabetes. , 1989, The Journal of bone and joint surgery. American volume.

[23]  D. Kaplan,et al.  VEGF and BMP-2 promote bone regeneration by facilitating bone marrow stem cell homing and differentiation. , 2014, European cells & materials.

[24]  W. Giannobile,et al.  Recombinant human bone morphogenetic protein 2 outcomes for maxillary sinus floor augmentation: a systematic review and meta-analysis. , 2016, Clinical oral implants research.

[25]  J. Fiorellini,et al.  Modulating the effects of diabetes on osseointegration with aminoguanidine and doxycycline. , 2005, Journal of periodontology.

[26]  C. Ge,et al.  Physical and functional interactions between Runx2 and HIF‐1α induce vascular endothelial growth factor gene expression , 2011, Journal of cellular biochemistry.

[27]  Stan Gronthos,et al.  Investigation of multipotent postnatal stem cells from human periodontal ligament , 2004, The Lancet.

[28]  W. Roberts,et al.  REMODELING DYNAMICS OF BONE SUPPORTING RIGIDLY FIXED TITANIUM IMPLANTS: A HISTOMORPHOMETRIC COMPARISON IN FOUR SPECIES INCLUDING HUMANS , 1995, Implant dentistry.

[29]  Q. Jin,et al.  Gene expression dynamics during bone healing and osseointegration. , 2011, Journal of periodontology.

[30]  Y. Ouchi,et al.  Glucocorticoid-induced gene tripartite motif-containing 63 (TRIM63) promotes differentiation of osteoblastic cells. , 2010, Endocrine journal.

[31]  Ning Zhang,et al.  Type 2 diabetes mellitus impairs bone healing of dental implants in GK rats. , 2010, Diabetes research and clinical practice.

[32]  J. Polak,et al.  Nitric oxide in fracture repair , 1999 .

[33]  J. Fiorellini,et al.  Maintenance of osseointegration utilizing insulin therapy in a diabetic rat model. , 2005, Journal of periodontology.

[34]  Bing Li,et al.  The melanoma-associated transmembrane glycoprotein Gpnmb controls trafficking of cellular debris for degradation and is essential for tissue repair. , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  A. Ahluwalia,et al.  Critical role of hypoxia sensor--HIF-1α in VEGF gene activation. Implications for angiogenesis and tissue injury healing. , 2012, Current medicinal chemistry.

[36]  Je-Yong Choi,et al.  Analysis of the Runx2 promoter in osseous and non-osseous cells and identification of HIF2A as a potent transcription activator. , 2008, Gene.

[37]  E. Elster,et al.  Comparative analysis of angiogenic gene expression in normal and impaired wound healing in diabetic mice: effects of extracorporeal shock wave therapy , 2010, Angiogenesis.

[38]  小倩,et al.  Fusion Rings for Degenerate Minimal Models , 2002 .

[39]  L. Poellinger,et al.  Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability and function. , 2004, Diabetes.

[40]  Edgar Wingender,et al.  The TRANSFAC project as an example of framework technology that supports the analysis of genomic regulation , 2008, Briefings Bioinform..